nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—SLC22A2—Cladribine—multiple sclerosis	0.214	0.255	CbGbCtD
Chlorphenamine—SLC22A1—Cladribine—multiple sclerosis	0.186	0.221	CbGbCtD
Chlorphenamine—CYP2D6—Fingolimod—multiple sclerosis	0.0833	0.0991	CbGbCtD
Chlorphenamine—CYP3A4—Fingolimod—multiple sclerosis	0.053	0.063	CbGbCtD
Chlorphenamine—CYP3A7—Dexamethasone—multiple sclerosis	0.0441	0.0525	CbGbCtD
Chlorphenamine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0441	0.0525	CbGbCtD
Chlorphenamine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0341	0.0406	CbGbCtD
Chlorphenamine—CYP3A5—Dexamethasone—multiple sclerosis	0.0331	0.0394	CbGbCtD
Chlorphenamine—CYP3A4—Triamcinolone—multiple sclerosis	0.0259	0.0308	CbGbCtD
Chlorphenamine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0249	0.0296	CbGbCtD
Chlorphenamine—CYP3A4—Betamethasone—multiple sclerosis	0.0222	0.0264	CbGbCtD
Chlorphenamine—CYP3A4—Prednisolone—multiple sclerosis	0.0219	0.0261	CbGbCtD
Chlorphenamine—CYP3A4—Prednisone—multiple sclerosis	0.0207	0.0246	CbGbCtD
Chlorphenamine—CYP2D6—Dexamethasone—multiple sclerosis	0.0203	0.0242	CbGbCtD
Chlorphenamine—CYP3A4—Dexamethasone—multiple sclerosis	0.0129	0.0154	CbGbCtD
Chlorphenamine—Neuritis—Cladribine—multiple sclerosis	0.00298	0.0238	CcSEcCtD
Chlorphenamine—Wheezing—Cladribine—multiple sclerosis	0.00216	0.0172	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Cladribine—multiple sclerosis	0.00179	0.0143	CcSEcCtD
Chlorphenamine—Vision blurred—Fingolimod—multiple sclerosis	0.00162	0.0129	CcSEcCtD
Chlorphenamine—Neuritis—Prednisolone—multiple sclerosis	0.00161	0.0128	CcSEcCtD
Chlorphenamine—Palpitations—Fingolimod—multiple sclerosis	0.00152	0.0121	CcSEcCtD
Chlorphenamine—Mydriasis—Prednisolone—multiple sclerosis	0.00151	0.012	CcSEcCtD
Chlorphenamine—Hypertension—Fingolimod—multiple sclerosis	0.00148	0.0118	CcSEcCtD
Chlorphenamine—Neuritis—Triamcinolone—multiple sclerosis	0.00148	0.0118	CcSEcCtD
Chlorphenamine—Neuritis—Methylprednisolone—multiple sclerosis	0.00148	0.0118	CcSEcCtD
Chlorphenamine—Sweating increased—Cladribine—multiple sclerosis	0.00136	0.0108	CcSEcCtD
Chlorphenamine—Neuritis—Dexamethasone—multiple sclerosis	0.00134	0.0107	CcSEcCtD
Chlorphenamine—Neuritis—Betamethasone—multiple sclerosis	0.00134	0.0107	CcSEcCtD
Chlorphenamine—Hypotension—Fingolimod—multiple sclerosis	0.00131	0.0104	CcSEcCtD
Chlorphenamine—Paraesthesia—Fingolimod—multiple sclerosis	0.00126	0.01	CcSEcCtD
Chlorphenamine—Fatigue—Fingolimod—multiple sclerosis	0.00121	0.00963	CcSEcCtD
Chlorphenamine—Neuritis—Prednisone—multiple sclerosis	0.00117	0.00931	CcSEcCtD
Chlorphenamine—Wheezing—Triamcinolone—multiple sclerosis	0.00107	0.00854	CcSEcCtD
Chlorphenamine—Euphoric mood—Prednisolone—multiple sclerosis	0.00103	0.00822	CcSEcCtD
Chlorphenamine—Asthenia—Fingolimod—multiple sclerosis	0.00101	0.00801	CcSEcCtD
Chlorphenamine—Chills—Cladribine—multiple sclerosis	0.001	0.00799	CcSEcCtD
Chlorphenamine—Diarrhoea—Fingolimod—multiple sclerosis	0.000959	0.00764	CcSEcCtD
Chlorphenamine—Euphoric mood—Triamcinolone—multiple sclerosis	0.000949	0.00756	CcSEcCtD
Chlorphenamine—Euphoric mood—Methylprednisolone—multiple sclerosis	0.000947	0.00754	CcSEcCtD
Chlorphenamine—Agranulocytosis—Azathioprine—multiple sclerosis	0.000946	0.00753	CcSEcCtD
Chlorphenamine—Dizziness—Fingolimod—multiple sclerosis	0.000927	0.00738	CcSEcCtD
Chlorphenamine—Sweating increased—Mitoxantrone—multiple sclerosis	0.000895	0.00713	CcSEcCtD
Chlorphenamine—Headache—Fingolimod—multiple sclerosis	0.000878	0.00699	CcSEcCtD
Chlorphenamine—Euphoric mood—Betamethasone—multiple sclerosis	0.000861	0.00686	CcSEcCtD
Chlorphenamine—Euphoric mood—Dexamethasone—multiple sclerosis	0.000861	0.00686	CcSEcCtD
Chlorphenamine—Anxiety—Cladribine—multiple sclerosis	0.000826	0.00658	CcSEcCtD
Chlorphenamine—Drowsiness—Mitoxantrone—multiple sclerosis	0.000819	0.00652	CcSEcCtD
Chlorphenamine—Chills—Azathioprine—multiple sclerosis	0.000816	0.0065	CcSEcCtD
Chlorphenamine—Confusional state—Cladribine—multiple sclerosis	0.000801	0.00638	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Cladribine—multiple sclerosis	0.000778	0.0062	CcSEcCtD
Chlorphenamine—Tachycardia—Cladribine—multiple sclerosis	0.000776	0.00618	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Cladribine—multiple sclerosis	0.000768	0.00612	CcSEcCtD
Chlorphenamine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000764	0.00609	CcSEcCtD
Chlorphenamine—Irritability—Methylprednisolone—multiple sclerosis	0.000764	0.00608	CcSEcCtD
Chlorphenamine—Anorexia—Cladribine—multiple sclerosis	0.000758	0.00603	CcSEcCtD
Chlorphenamine—Euphoric mood—Prednisone—multiple sclerosis	0.00075	0.00597	CcSEcCtD
Chlorphenamine—Hypotension—Cladribine—multiple sclerosis	0.000743	0.00591	CcSEcCtD
Chlorphenamine—Sweating increased—Prednisolone—multiple sclerosis	0.000734	0.00585	CcSEcCtD
Chlorphenamine—Insomnia—Cladribine—multiple sclerosis	0.000719	0.00572	CcSEcCtD
Chlorphenamine—Paraesthesia—Cladribine—multiple sclerosis	0.000714	0.00568	CcSEcCtD
Chlorphenamine—Somnolence—Cladribine—multiple sclerosis	0.000707	0.00563	CcSEcCtD
Chlorphenamine—Irritability—Dexamethasone—multiple sclerosis	0.000694	0.00553	CcSEcCtD
Chlorphenamine—Irritability—Betamethasone—multiple sclerosis	0.000694	0.00553	CcSEcCtD
Chlorphenamine—Decreased appetite—Cladribine—multiple sclerosis	0.000691	0.0055	CcSEcCtD
Chlorphenamine—Fatigue—Cladribine—multiple sclerosis	0.000685	0.00546	CcSEcCtD
Chlorphenamine—Constipation—Cladribine—multiple sclerosis	0.00068	0.00541	CcSEcCtD
Chlorphenamine—Sweating increased—Triamcinolone—multiple sclerosis	0.000675	0.00538	CcSEcCtD
Chlorphenamine—Sweating increased—Methylprednisolone—multiple sclerosis	0.000674	0.00536	CcSEcCtD
Chlorphenamine—Chills—Mitoxantrone—multiple sclerosis	0.00066	0.00525	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000659	0.00525	CcSEcCtD
Chlorphenamine—Feeling abnormal—Cladribine—multiple sclerosis	0.000655	0.00522	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000633	0.00504	CcSEcCtD
Chlorphenamine—Sweating increased—Betamethasone—multiple sclerosis	0.000613	0.00488	CcSEcCtD
Chlorphenamine—Sweating increased—Dexamethasone—multiple sclerosis	0.000613	0.00488	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000606	0.00482	CcSEcCtD
Chlorphenamine—Irritability—Prednisone—multiple sclerosis	0.000605	0.00482	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000604	0.00481	CcSEcCtD
Chlorphenamine—Hypotension—Azathioprine—multiple sclerosis	0.000604	0.00481	CcSEcCtD
Chlorphenamine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000603	0.0048	CcSEcCtD
Chlorphenamine—Photosensitivity—Methotrexate—multiple sclerosis	0.000603	0.0048	CcSEcCtD
Chlorphenamine—Asthenia—Cladribine—multiple sclerosis	0.00057	0.00454	CcSEcCtD
Chlorphenamine—Convulsion—Mitoxantrone—multiple sclerosis	0.000555	0.00442	CcSEcCtD
Chlorphenamine—Hypertension—Mitoxantrone—multiple sclerosis	0.000553	0.0044	CcSEcCtD
Chlorphenamine—Hallucination—Methylprednisolone—multiple sclerosis	0.000551	0.00439	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.00055	0.00438	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.00055	0.00438	CcSEcCtD
Chlorphenamine—Diarrhoea—Cladribine—multiple sclerosis	0.000544	0.00433	CcSEcCtD
Chlorphenamine—Anxiety—Mitoxantrone—multiple sclerosis	0.000543	0.00432	CcSEcCtD
Chlorphenamine—Sweating increased—Prednisone—multiple sclerosis	0.000533	0.00425	CcSEcCtD
Chlorphenamine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000533	0.00424	CcSEcCtD
Chlorphenamine—Confusional state—Mitoxantrone—multiple sclerosis	0.000527	0.00419	CcSEcCtD
Chlorphenamine—Dizziness—Cladribine—multiple sclerosis	0.000526	0.00418	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000511	0.00407	CcSEcCtD
Chlorphenamine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00051	0.00406	CcSEcCtD
Chlorphenamine—Irritability—Methotrexate—multiple sclerosis	0.000505	0.00402	CcSEcCtD
Chlorphenamine—Vomiting—Cladribine—multiple sclerosis	0.000505	0.00402	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000505	0.00402	CcSEcCtD
Chlorphenamine—Hallucination—Dexamethasone—multiple sclerosis	0.000501	0.00399	CcSEcCtD
Chlorphenamine—Hallucination—Betamethasone—multiple sclerosis	0.000501	0.00399	CcSEcCtD
Chlorphenamine—Anorexia—Mitoxantrone—multiple sclerosis	0.000498	0.00397	CcSEcCtD
Chlorphenamine—Headache—Cladribine—multiple sclerosis	0.000498	0.00396	CcSEcCtD
Chlorphenamine—Vision blurred—Prednisolone—multiple sclerosis	0.000495	0.00394	CcSEcCtD
Chlorphenamine—Hypotension—Mitoxantrone—multiple sclerosis	0.000488	0.00389	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000479	0.00381	CcSEcCtD
Chlorphenamine—Nausea—Cladribine—multiple sclerosis	0.000472	0.00376	CcSEcCtD
Chlorphenamine—Vertigo—Prednisolone—multiple sclerosis	0.000472	0.00376	CcSEcCtD
Chlorphenamine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000469	0.00374	CcSEcCtD
Chlorphenamine—Somnolence—Mitoxantrone—multiple sclerosis	0.000464	0.0037	CcSEcCtD
Chlorphenamine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00046	0.00366	CcSEcCtD
Chlorphenamine—Convulsion—Prednisolone—multiple sclerosis	0.000455	0.00362	CcSEcCtD
Chlorphenamine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000454	0.00362	CcSEcCtD
Chlorphenamine—Hypertension—Prednisolone—multiple sclerosis	0.000453	0.00361	CcSEcCtD
Chlorphenamine—Fatigue—Mitoxantrone—multiple sclerosis	0.00045	0.00359	CcSEcCtD
Chlorphenamine—Constipation—Mitoxantrone—multiple sclerosis	0.000447	0.00356	CcSEcCtD
Chlorphenamine—Diarrhoea—Azathioprine—multiple sclerosis	0.000442	0.00352	CcSEcCtD
Chlorphenamine—Hallucination—Prednisone—multiple sclerosis	0.000436	0.00347	CcSEcCtD
Chlorphenamine—Vertigo—Triamcinolone—multiple sclerosis	0.000434	0.00345	CcSEcCtD
Chlorphenamine—Vertigo—Methylprednisolone—multiple sclerosis	0.000433	0.00345	CcSEcCtD
Chlorphenamine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00043	0.00343	CcSEcCtD
Chlorphenamine—Dizziness—Azathioprine—multiple sclerosis	0.000427	0.0034	CcSEcCtD
Chlorphenamine—Convulsion—Triamcinolone—multiple sclerosis	0.000418	0.00333	CcSEcCtD
Chlorphenamine—Tachycardia—Prednisolone—multiple sclerosis	0.000418	0.00333	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000418	0.00333	CcSEcCtD
Chlorphenamine—Convulsion—Methylprednisolone—multiple sclerosis	0.000417	0.00332	CcSEcCtD
Chlorphenamine—Hypertension—Triamcinolone—multiple sclerosis	0.000417	0.00332	CcSEcCtD
Chlorphenamine—Hypertension—Methylprednisolone—multiple sclerosis	0.000416	0.00331	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000414	0.0033	CcSEcCtD
Chlorphenamine—Vomiting—Azathioprine—multiple sclerosis	0.000411	0.00327	CcSEcCtD
Chlorphenamine—Anxiety—Methylprednisolone—multiple sclerosis	0.000409	0.00326	CcSEcCtD
Chlorphenamine—Drowsiness—Methotrexate—multiple sclerosis	0.000408	0.00325	CcSEcCtD
Chlorphenamine—Headache—Azathioprine—multiple sclerosis	0.000405	0.00322	CcSEcCtD
Chlorphenamine—Dry mouth—Triamcinolone—multiple sclerosis	0.000402	0.0032	CcSEcCtD
Chlorphenamine—Confusional state—Methylprednisolone—multiple sclerosis	0.000397	0.00316	CcSEcCtD
Chlorphenamine—Vertigo—Dexamethasone—multiple sclerosis	0.000394	0.00313	CcSEcCtD
Chlorphenamine—Vertigo—Betamethasone—multiple sclerosis	0.000394	0.00313	CcSEcCtD
Chlorphenamine—Insomnia—Prednisolone—multiple sclerosis	0.000388	0.00309	CcSEcCtD
Chlorphenamine—Paraesthesia—Prednisolone—multiple sclerosis	0.000385	0.00306	CcSEcCtD
Chlorphenamine—Tachycardia—Triamcinolone—multiple sclerosis	0.000385	0.00306	CcSEcCtD
Chlorphenamine—Nausea—Azathioprine—multiple sclerosis	0.000384	0.00306	CcSEcCtD
Chlorphenamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000384	0.00306	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000381	0.00303	CcSEcCtD
Chlorphenamine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000381	0.00303	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00038	0.00303	CcSEcCtD
Chlorphenamine—Convulsion—Betamethasone—multiple sclerosis	0.00038	0.00302	CcSEcCtD
Chlorphenamine—Convulsion—Dexamethasone—multiple sclerosis	0.00038	0.00302	CcSEcCtD
Chlorphenamine—Hypertension—Dexamethasone—multiple sclerosis	0.000378	0.00301	CcSEcCtD
Chlorphenamine—Hypertension—Betamethasone—multiple sclerosis	0.000378	0.00301	CcSEcCtD
Chlorphenamine—Asthenia—Mitoxantrone—multiple sclerosis	0.000375	0.00298	CcSEcCtD
Chlorphenamine—Anxiety—Dexamethasone—multiple sclerosis	0.000372	0.00296	CcSEcCtD
Chlorphenamine—Anxiety—Betamethasone—multiple sclerosis	0.000372	0.00296	CcSEcCtD
Chlorphenamine—Hypotension—Methylprednisolone—multiple sclerosis	0.000367	0.00293	CcSEcCtD
Chlorphenamine—Vision blurred—Prednisone—multiple sclerosis	0.00036	0.00286	CcSEcCtD
Chlorphenamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000357	0.00285	CcSEcCtD
Chlorphenamine—Insomnia—Triamcinolone—multiple sclerosis	0.000356	0.00284	CcSEcCtD
Chlorphenamine—Insomnia—Methylprednisolone—multiple sclerosis	0.000356	0.00283	CcSEcCtD
Chlorphenamine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000354	0.00282	CcSEcCtD
Chlorphenamine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000353	0.00281	CcSEcCtD
Chlorphenamine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000353	0.00281	CcSEcCtD
Chlorphenamine—Agitation—Prednisone—multiple sclerosis	0.000351	0.00279	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00035	0.00279	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00035	0.00279	CcSEcCtD
Chlorphenamine—SLC6A3—nerve—multiple sclerosis	0.000349	0.127	CbGeAlD
Chlorphenamine—Tachycardia—Dexamethasone—multiple sclerosis	0.000349	0.00278	CcSEcCtD
Chlorphenamine—Tachycardia—Betamethasone—multiple sclerosis	0.000349	0.00278	CcSEcCtD
Chlorphenamine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000347	0.00276	CcSEcCtD
Chlorphenamine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000346	0.00276	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000346	0.00275	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000346	0.00275	CcSEcCtD
Chlorphenamine—Vertigo—Prednisone—multiple sclerosis	0.000343	0.00273	CcSEcCtD
Chlorphenamine—Tinnitus—Methotrexate—multiple sclerosis	0.000342	0.00272	CcSEcCtD
Chlorphenamine—Anorexia—Dexamethasone—multiple sclerosis	0.000341	0.00271	CcSEcCtD
Chlorphenamine—Anorexia—Betamethasone—multiple sclerosis	0.000341	0.00271	CcSEcCtD
Chlorphenamine—Fatigue—Triamcinolone—multiple sclerosis	0.00034	0.00271	CcSEcCtD
Chlorphenamine—Fatigue—Methylprednisolone—multiple sclerosis	0.000339	0.0027	CcSEcCtD
Chlorphenamine—Hypotension—Betamethasone—multiple sclerosis	0.000334	0.00266	CcSEcCtD
Chlorphenamine—Hypotension—Dexamethasone—multiple sclerosis	0.000334	0.00266	CcSEcCtD
Chlorphenamine—Vomiting—Mitoxantrone—multiple sclerosis	0.000332	0.00264	CcSEcCtD
Chlorphenamine—Convulsion—Prednisone—multiple sclerosis	0.000331	0.00263	CcSEcCtD
Chlorphenamine—Hypertension—Prednisone—multiple sclerosis	0.000329	0.00262	CcSEcCtD
Chlorphenamine—Chills—Methotrexate—multiple sclerosis	0.000329	0.00262	CcSEcCtD
Chlorphenamine—Headache—Mitoxantrone—multiple sclerosis	0.000327	0.00261	CcSEcCtD
Chlorphenamine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000325	0.00259	CcSEcCtD
Chlorphenamine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000324	0.00258	CcSEcCtD
Chlorphenamine—Anxiety—Prednisone—multiple sclerosis	0.000324	0.00258	CcSEcCtD
Chlorphenamine—Insomnia—Betamethasone—multiple sclerosis	0.000323	0.00258	CcSEcCtD
Chlorphenamine—Insomnia—Dexamethasone—multiple sclerosis	0.000323	0.00258	CcSEcCtD
Chlorphenamine—Paraesthesia—Betamethasone—multiple sclerosis	0.000321	0.00256	CcSEcCtD
Chlorphenamine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000321	0.00256	CcSEcCtD
Chlorphenamine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000315	0.00251	CcSEcCtD
Chlorphenamine—Dyspepsia—Betamethasone—multiple sclerosis	0.000315	0.00251	CcSEcCtD
Chlorphenamine—Decreased appetite—Betamethasone—multiple sclerosis	0.000311	0.00248	CcSEcCtD
Chlorphenamine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000311	0.00248	CcSEcCtD
Chlorphenamine—Nausea—Mitoxantrone—multiple sclerosis	0.00031	0.00247	CcSEcCtD
Chlorphenamine—Fatigue—Betamethasone—multiple sclerosis	0.000308	0.00246	CcSEcCtD
Chlorphenamine—Fatigue—Dexamethasone—multiple sclerosis	0.000308	0.00246	CcSEcCtD
Chlorphenamine—Tachycardia—Prednisone—multiple sclerosis	0.000304	0.00242	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000301	0.0024	CcSEcCtD
Chlorphenamine—Vision blurred—Methotrexate—multiple sclerosis	0.000301	0.00239	CcSEcCtD
Chlorphenamine—Anorexia—Prednisone—multiple sclerosis	0.000297	0.00236	CcSEcCtD
Chlorphenamine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000295	0.00235	CcSEcCtD
Chlorphenamine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000295	0.00235	CcSEcCtD
Chlorphenamine—Vertigo—Methotrexate—multiple sclerosis	0.000287	0.00228	CcSEcCtD
Chlorphenamine—Dizziness—Prednisolone—multiple sclerosis	0.000283	0.00226	CcSEcCtD
Chlorphenamine—Asthenia—Triamcinolone—multiple sclerosis	0.000283	0.00225	CcSEcCtD
Chlorphenamine—Asthenia—Methylprednisolone—multiple sclerosis	0.000282	0.00225	CcSEcCtD
Chlorphenamine—Insomnia—Prednisone—multiple sclerosis	0.000282	0.00224	CcSEcCtD
Chlorphenamine—SLC6A2—nerve—multiple sclerosis	0.000282	0.103	CbGeAlD
Chlorphenamine—Paraesthesia—Prednisone—multiple sclerosis	0.00028	0.00223	CcSEcCtD
Chlorphenamine—Convulsion—Methotrexate—multiple sclerosis	0.000276	0.0022	CcSEcCtD
Chlorphenamine—Dyspepsia—Prednisone—multiple sclerosis	0.000274	0.00218	CcSEcCtD
Chlorphenamine—Decreased appetite—Prednisone—multiple sclerosis	0.000271	0.00216	CcSEcCtD
Chlorphenamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000269	0.00214	CcSEcCtD
Chlorphenamine—Fatigue—Prednisone—multiple sclerosis	0.000269	0.00214	CcSEcCtD
Chlorphenamine—Headache—Prednisolone—multiple sclerosis	0.000268	0.00214	CcSEcCtD
Chlorphenamine—Constipation—Prednisone—multiple sclerosis	0.000266	0.00212	CcSEcCtD
Chlorphenamine—Confusional state—Methotrexate—multiple sclerosis	0.000262	0.00209	CcSEcCtD
Chlorphenamine—Dizziness—Triamcinolone—multiple sclerosis	0.000261	0.00208	CcSEcCtD
Chlorphenamine—Dizziness—Methylprednisolone—multiple sclerosis	0.00026	0.00207	CcSEcCtD
Chlorphenamine—Feeling abnormal—Prednisone—multiple sclerosis	0.000257	0.00204	CcSEcCtD
Chlorphenamine—Asthenia—Dexamethasone—multiple sclerosis	0.000257	0.00204	CcSEcCtD
Chlorphenamine—Asthenia—Betamethasone—multiple sclerosis	0.000257	0.00204	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000255	0.00203	CcSEcCtD
Chlorphenamine—Nausea—Prednisolone—multiple sclerosis	0.000255	0.00203	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000252	0.002	CcSEcCtD
Chlorphenamine—Vomiting—Triamcinolone—multiple sclerosis	0.000251	0.002	CcSEcCtD
Chlorphenamine—Vomiting—Methylprednisolone—multiple sclerosis	0.00025	0.00199	CcSEcCtD
Chlorphenamine—Anorexia—Methotrexate—multiple sclerosis	0.000248	0.00198	CcSEcCtD
Chlorphenamine—Headache—Triamcinolone—multiple sclerosis	0.000247	0.00197	CcSEcCtD
Chlorphenamine—Headache—Methylprednisolone—multiple sclerosis	0.000246	0.00196	CcSEcCtD
Chlorphenamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000245	0.00195	CcSEcCtD
Chlorphenamine—Diarrhoea—Betamethasone—multiple sclerosis	0.000245	0.00195	CcSEcCtD
Chlorphenamine—Hypotension—Methotrexate—multiple sclerosis	0.000243	0.00194	CcSEcCtD
Chlorphenamine—Dizziness—Dexamethasone—multiple sclerosis	0.000236	0.00188	CcSEcCtD
Chlorphenamine—Dizziness—Betamethasone—multiple sclerosis	0.000236	0.00188	CcSEcCtD
Chlorphenamine—Insomnia—Methotrexate—multiple sclerosis	0.000235	0.00187	CcSEcCtD
Chlorphenamine—Nausea—Triamcinolone—multiple sclerosis	0.000234	0.00186	CcSEcCtD
Chlorphenamine—Paraesthesia—Methotrexate—multiple sclerosis	0.000234	0.00186	CcSEcCtD
Chlorphenamine—Nausea—Methylprednisolone—multiple sclerosis	0.000234	0.00186	CcSEcCtD
Chlorphenamine—Somnolence—Methotrexate—multiple sclerosis	0.000231	0.00184	CcSEcCtD
Chlorphenamine—Dyspepsia—Methotrexate—multiple sclerosis	0.000229	0.00182	CcSEcCtD
Chlorphenamine—Vomiting—Dexamethasone—multiple sclerosis	0.000227	0.00181	CcSEcCtD
Chlorphenamine—Vomiting—Betamethasone—multiple sclerosis	0.000227	0.00181	CcSEcCtD
Chlorphenamine—Decreased appetite—Methotrexate—multiple sclerosis	0.000226	0.0018	CcSEcCtD
Chlorphenamine—Fatigue—Methotrexate—multiple sclerosis	0.000224	0.00179	CcSEcCtD
Chlorphenamine—Headache—Betamethasone—multiple sclerosis	0.000224	0.00178	CcSEcCtD
Chlorphenamine—Headache—Dexamethasone—multiple sclerosis	0.000224	0.00178	CcSEcCtD
Chlorphenamine—Asthenia—Prednisone—multiple sclerosis	0.000223	0.00178	CcSEcCtD
Chlorphenamine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000214	0.00171	CcSEcCtD
Chlorphenamine—Diarrhoea—Prednisone—multiple sclerosis	0.000213	0.0017	CcSEcCtD
Chlorphenamine—Nausea—Betamethasone—multiple sclerosis	0.000212	0.00169	CcSEcCtD
Chlorphenamine—Nausea—Dexamethasone—multiple sclerosis	0.000212	0.00169	CcSEcCtD
Chlorphenamine—Dizziness—Prednisone—multiple sclerosis	0.000206	0.00164	CcSEcCtD
Chlorphenamine—Vomiting—Prednisone—multiple sclerosis	0.000198	0.00158	CcSEcCtD
Chlorphenamine—Headache—Prednisone—multiple sclerosis	0.000195	0.00155	CcSEcCtD
Chlorphenamine—Asthenia—Methotrexate—multiple sclerosis	0.000187	0.00149	CcSEcCtD
Chlorphenamine—Nausea—Prednisone—multiple sclerosis	0.000185	0.00147	CcSEcCtD
Chlorphenamine—Diarrhoea—Methotrexate—multiple sclerosis	0.000178	0.00142	CcSEcCtD
Chlorphenamine—Dizziness—Methotrexate—multiple sclerosis	0.000172	0.00137	CcSEcCtD
Chlorphenamine—Vomiting—Methotrexate—multiple sclerosis	0.000165	0.00132	CcSEcCtD
Chlorphenamine—Headache—Methotrexate—multiple sclerosis	0.000163	0.0013	CcSEcCtD
Chlorphenamine—SLC6A3—Monoamine Transport—IL1B—multiple sclerosis	0.00016	0.00512	CbGpPWpGaD
Chlorphenamine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00016	0.0051	CbGpPWpGaD
Chlorphenamine—Nausea—Methotrexate—multiple sclerosis	0.000155	0.00123	CcSEcCtD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—IL4—multiple sclerosis	0.000154	0.00493	CbGpPWpGaD
Chlorphenamine—SLC6A4—Monoamine Transport—TNF—multiple sclerosis	0.000153	0.00488	CbGpPWpGaD
Chlorphenamine—SLC6A3—brainstem—multiple sclerosis	0.00015	0.0547	CbGeAlD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000146	0.00468	CbGpPWpGaD
Chlorphenamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000144	0.00461	CbGpPWpGaD
Chlorphenamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000144	0.00461	CbGpPWpGaD
Chlorphenamine—SLC6A3—Dopaminergic Neurogenesis—STAT3—multiple sclerosis	0.000141	0.00452	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00014	0.00446	CbGpPWpGaD
Chlorphenamine—SLC6A4—brainstem—multiple sclerosis	0.000137	0.0501	CbGeAlD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000133	0.00426	CbGpPWpGaD
Chlorphenamine—SLC6A2—Monoamine Transport—TNF—multiple sclerosis	0.000131	0.00419	CbGpPWpGaD
Chlorphenamine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—multiple sclerosis	0.000131	0.00419	CbGpPWpGaD
Chlorphenamine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000127	0.00407	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.000125	0.00399	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000124	0.00397	CbGpPWpGaD
Chlorphenamine—SLC6A2—brainstem—multiple sclerosis	0.000121	0.0441	CbGeAlD
Chlorphenamine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000119	0.0038	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000118	0.00378	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000117	0.00374	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000117	0.00374	CbGpPWpGaD
Chlorphenamine—SLC6A3—Monoamine Transport—TNF—multiple sclerosis	0.000116	0.00372	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000115	0.00369	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000115	0.00369	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000115	0.00369	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000115	0.00367	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000113	0.00361	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000111	0.00354	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000108	0.00345	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000102	0.00327	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—TYK2—multiple sclerosis	9.95e-05	0.00318	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	9.88e-05	0.00316	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.82e-05	0.00314	CbGpPWpGaD
Chlorphenamine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.65e-05	0.00308	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	9.64e-05	0.00308	CbGpPWpGaD
Chlorphenamine—SLC6A3—midbrain—multiple sclerosis	9.55e-05	0.0349	CbGeAlD
Chlorphenamine—SLC6A3—spinal cord—multiple sclerosis	9.32e-05	0.034	CbGeAlD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	9.31e-05	0.00297	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	9.25e-05	0.00296	CbGpPWpGaD
Chlorphenamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	9.16e-05	0.00293	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.93e-05	0.00285	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.78e-05	0.0028	CbGpPWpGaD
Chlorphenamine—SLC6A4—midbrain—multiple sclerosis	8.75e-05	0.032	CbGeAlD
Chlorphenamine—HRH1—GPCR ligand binding—S1PR1—multiple sclerosis	8.74e-05	0.00279	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.68e-05	0.00277	CbGpPWpGaD
Chlorphenamine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.6e-05	0.00275	CbGpPWpGaD
Chlorphenamine—SLC6A4—spinal cord—multiple sclerosis	8.54e-05	0.0312	CbGeAlD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	8.46e-05	0.0027	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	8.46e-05	0.0027	CbGpPWpGaD
Chlorphenamine—SLC6A2—medulla oblongata—multiple sclerosis	8.43e-05	0.0308	CbGeAlD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.4e-05	0.00268	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.33e-05	0.00266	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—FAS—multiple sclerosis	8.27e-05	0.00264	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.18e-05	0.00261	CbGpPWpGaD
Chlorphenamine—SLC6A3—nervous system—multiple sclerosis	7.85e-05	0.0287	CbGeAlD
Chlorphenamine—SLC22A1—nervous system—multiple sclerosis	7.73e-05	0.0282	CbGeAlD
Chlorphenamine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	7.66e-05	0.00245	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	7.66e-05	0.00245	CbGpPWpGaD
Chlorphenamine—SLC6A3—central nervous system—multiple sclerosis	7.56e-05	0.0276	CbGeAlD
Chlorphenamine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.55e-05	0.00241	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.55e-05	0.00241	CbGpPWpGaD
Chlorphenamine—SLC22A1—central nervous system—multiple sclerosis	7.45e-05	0.0272	CbGeAlD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.44e-05	0.00238	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—BCHE—multiple sclerosis	7.39e-05	0.00236	CbGpPWpGaD
Chlorphenamine—SLC6A3—cerebellum—multiple sclerosis	7.39e-05	0.027	CbGeAlD
Chlorphenamine—SLC6A4—nervous system—multiple sclerosis	7.19e-05	0.0263	CbGeAlD
Chlorphenamine—HRH1—GPCR ligand binding—GPR65—multiple sclerosis	7.05e-05	0.00225	CbGpPWpGaD
Chlorphenamine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.97e-05	0.00223	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—STAT3—multiple sclerosis	6.97e-05	0.00223	CbGpPWpGaD
Chlorphenamine—SLC6A4—central nervous system—multiple sclerosis	6.93e-05	0.0253	CbGeAlD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	6.77e-05	0.00216	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.77e-05	0.00216	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—BCHE—multiple sclerosis	6.72e-05	0.00215	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.64e-05	0.00212	CbGpPWpGaD
Chlorphenamine—CYP2D6—brainstem—multiple sclerosis	6.62e-05	0.0242	CbGeAlD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	6.54e-05	0.00209	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CCR1—multiple sclerosis	6.44e-05	0.00206	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CXCL13—multiple sclerosis	6.44e-05	0.00206	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	6.36e-05	0.00203	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—MAPK1—multiple sclerosis	6.33e-05	0.00202	CbGpPWpGaD
Chlorphenamine—SLC6A2—nervous system—multiple sclerosis	6.33e-05	0.0231	CbGeAlD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.31e-05	0.00202	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—BCHE—multiple sclerosis	6.27e-05	0.002	CbGpPWpGaD
Chlorphenamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.12e-05	0.00195	CbGpPWpGaD
Chlorphenamine—SLC6A2—central nervous system—multiple sclerosis	6.1e-05	0.0223	CbGeAlD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	6.03e-05	0.00193	CbGpPWpGaD
Chlorphenamine—SLC6A3—brain—multiple sclerosis	6e-05	0.0219	CbGeAlD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.92e-05	0.00189	CbGpPWpGaD
Chlorphenamine—SLC22A1—brain—multiple sclerosis	5.91e-05	0.0216	CbGeAlD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.88e-05	0.00188	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	5.87e-05	0.00188	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.87e-05	0.00188	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	5.8e-05	0.00185	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	5.61e-05	0.00179	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—SRM—multiple sclerosis	5.53e-05	0.00177	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—SRM—multiple sclerosis	5.52e-05	0.00176	CbGpPWpGaD
Chlorphenamine—SLC6A4—brain—multiple sclerosis	5.5e-05	0.0201	CbGeAlD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	5.45e-05	0.00174	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.35e-05	0.00171	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.2e-05	0.00166	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—SRM—multiple sclerosis	5.15e-05	0.00164	CbGpPWpGaD
Chlorphenamine—CYP3A7—Biological oxidations—POMC—multiple sclerosis	5.12e-05	0.00164	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	5.03e-05	0.00161	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.99e-05	0.00159	CbGpPWpGaD
Chlorphenamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.96e-05	0.00158	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—S1PR1—multiple sclerosis	4.94e-05	0.00158	CbGpPWpGaD
Chlorphenamine—SLC6A4—NRF2 pathway—TGFB1—multiple sclerosis	4.85e-05	0.00155	CbGpPWpGaD
Chlorphenamine—SLC6A2—brain—multiple sclerosis	4.84e-05	0.0177	CbGeAlD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.73e-05	0.00151	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CCL3—multiple sclerosis	4.59e-05	0.00147	CbGpPWpGaD
Chlorphenamine—HRH1—nervous system—multiple sclerosis	4.56e-05	0.0166	CbGeAlD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	4.53e-05	0.00145	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—S1PR1—multiple sclerosis	4.49e-05	0.00143	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—PTGER4—multiple sclerosis	4.42e-05	0.00141	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.41e-05	0.00141	CbGpPWpGaD
Chlorphenamine—HRH1—central nervous system—multiple sclerosis	4.39e-05	0.016	CbGeAlD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.3e-05	0.00137	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CXCR3—multiple sclerosis	4.27e-05	0.00136	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—RGS1—multiple sclerosis	4.2e-05	0.00134	CbGpPWpGaD
Chlorphenamine—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	4.17e-05	0.00133	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.16e-05	0.00133	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CCR2—multiple sclerosis	4.15e-05	0.00133	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	4.1e-05	0.00131	CbGpPWpGaD
Chlorphenamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4e-05	0.00128	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—SRM—multiple sclerosis	4e-05	0.00128	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—GPR65—multiple sclerosis	3.98e-05	0.00127	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	3.9e-05	0.00125	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	3.9e-05	0.00124	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	3.9e-05	0.00124	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	3.89e-05	0.00124	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	3.89e-05	0.00124	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CNR1—multiple sclerosis	3.83e-05	0.00122	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—RGS1—multiple sclerosis	3.81e-05	0.00122	CbGpPWpGaD
Chlorphenamine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.7e-05	0.00118	CbGpPWpGaD
Chlorphenamine—SLC6A3—NRF2 pathway—TGFB1—multiple sclerosis	3.7e-05	0.00118	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.68e-05	0.00118	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CCR1—multiple sclerosis	3.64e-05	0.00116	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CXCL13—multiple sclerosis	3.64e-05	0.00116	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	3.63e-05	0.00116	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	3.63e-05	0.00116	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—GPR65—multiple sclerosis	3.62e-05	0.00116	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GPC5—multiple sclerosis	3.56e-05	0.00114	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GPC5—multiple sclerosis	3.56e-05	0.00114	CbGpPWpGaD
Chlorphenamine—CYP3A4—nervous system—multiple sclerosis	3.52e-05	0.0129	CbGeAlD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	3.51e-05	0.00112	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—LINGO1—multiple sclerosis	3.5e-05	0.00112	CbGpPWpGaD
Chlorphenamine—HRH1—brain—multiple sclerosis	3.48e-05	0.0127	CbGeAlD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.47e-05	0.00111	CbGpPWpGaD
Chlorphenamine—CYP2D6—nervous system—multiple sclerosis	3.47e-05	0.0127	CbGeAlD
Chlorphenamine—HRH1—GPCR ligand binding—CXCL10—multiple sclerosis	3.45e-05	0.0011	CbGpPWpGaD
Chlorphenamine—CYP3A4—central nervous system—multiple sclerosis	3.39e-05	0.0124	CbGeAlD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.35e-05	0.00107	CbGpPWpGaD
Chlorphenamine—CYP2D6—central nervous system—multiple sclerosis	3.34e-05	0.0122	CbGeAlD
Chlorphenamine—SLC22A1—Metabolism—GPC5—multiple sclerosis	3.32e-05	0.00106	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CXCL13—multiple sclerosis	3.31e-05	0.00106	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CCR1—multiple sclerosis	3.31e-05	0.00106	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	3.3e-05	0.00105	CbGpPWpGaD
Chlorphenamine—CYP2D6—cerebellum—multiple sclerosis	3.26e-05	0.0119	CbGeAlD
Chlorphenamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.24e-05	0.00104	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.12e-05	0.000998	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TAGAP—multiple sclerosis	3.03e-05	0.000969	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CCL5—multiple sclerosis	2.97e-05	0.000949	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.95e-05	0.000943	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—RRM1—multiple sclerosis	2.95e-05	0.000942	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—SRM—multiple sclerosis	2.84e-05	0.000908	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—IL6—multiple sclerosis	2.83e-05	0.000905	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.82e-05	0.000901	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.82e-05	0.0009	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.82e-05	0.0009	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—RRM1—multiple sclerosis	2.75e-05	0.000878	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.75e-05	0.000878	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.69e-05	0.000859	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CCR5—multiple sclerosis	2.68e-05	0.000855	CbGpPWpGaD
Chlorphenamine—CYP2D6—brain—multiple sclerosis	2.65e-05	0.00968	CbGeAlD
Chlorphenamine—HRH1—Signaling Pathways—S1PR1—multiple sclerosis	2.65e-05	0.000847	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.63e-05	0.000842	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GPC5—multiple sclerosis	2.58e-05	0.000824	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.58e-05	0.000823	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.56e-05	0.00082	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	2.5e-05	0.000798	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	2.41e-05	0.000771	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.39e-05	0.000764	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	2.36e-05	0.000753	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	2.35e-05	0.00075	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	2.27e-05	0.000725	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RGS1—multiple sclerosis	2.25e-05	0.00072	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	2.19e-05	0.0007	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	2.17e-05	0.000692	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	2.16e-05	0.00069	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GPR65—multiple sclerosis	2.14e-05	0.000683	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.13e-05	0.000682	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	2.13e-05	0.000681	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.11e-05	0.000675	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.1e-05	0.00067	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—POMC—multiple sclerosis	2.09e-05	0.000668	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	2.05e-05	0.000654	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2e-05	0.00064	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2e-05	0.00064	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	1.97e-05	0.000628	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	1.97e-05	0.000628	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCR1—multiple sclerosis	1.95e-05	0.000624	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	1.95e-05	0.000624	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	1.95e-05	0.000623	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.87e-05	0.000598	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.86e-05	0.000594	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.83e-05	0.000585	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.83e-05	0.000585	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	1.77e-05	0.000566	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.72e-05	0.00055	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.7e-05	0.000544	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.7e-05	0.000542	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—BCHE—multiple sclerosis	1.69e-05	0.000541	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	1.68e-05	0.000536	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.61e-05	0.000515	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.59e-05	0.000507	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.58e-05	0.000504	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	1.52e-05	0.000487	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.52e-05	0.000485	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	1.51e-05	0.000483	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.49e-05	0.000476	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	1.39e-05	0.000445	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	1.37e-05	0.000439	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	1.35e-05	0.000432	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	1.34e-05	0.000428	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PGR—multiple sclerosis	1.32e-05	0.000422	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.31e-05	0.000418	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.31e-05	0.000418	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	1.29e-05	0.000414	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CD28—multiple sclerosis	1.28e-05	0.00041	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	1.26e-05	0.000402	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.23e-05	0.000392	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.2e-05	0.000383	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	1.18e-05	0.000378	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	1.16e-05	0.000371	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	1.07e-05	0.000343	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	1.05e-05	0.000336	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	1.05e-05	0.000334	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—APOE—multiple sclerosis	1.02e-05	0.000326	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—APOE—multiple sclerosis	1.02e-05	0.000325	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—RRM1—multiple sclerosis	9.92e-06	0.000317	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	9.54e-06	0.000305	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—APOE—multiple sclerosis	9.49e-06	0.000303	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CD86—multiple sclerosis	9.15e-06	0.000292	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	9e-06	0.000288	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—POMC—multiple sclerosis	8.76e-06	0.00028	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—POMC—multiple sclerosis	8.75e-06	0.00028	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	8.74e-06	0.000279	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—BCHE—multiple sclerosis	8.72e-06	0.000279	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	8.34e-06	0.000266	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—POMC—multiple sclerosis	8.16e-06	0.000261	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	8.11e-06	0.000259	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	7.99e-06	0.000255	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—ALB—multiple sclerosis	7.99e-06	0.000255	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—ALB—multiple sclerosis	7.98e-06	0.000255	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	7.93e-06	0.000254	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—ALB—multiple sclerosis	7.44e-06	0.000238	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—APOE—multiple sclerosis	7.38e-06	0.000236	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—APOE—multiple sclerosis	7.37e-06	0.000236	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CD80—multiple sclerosis	6.67e-06	0.000213	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—POMC—multiple sclerosis	6.34e-06	0.000203	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—POMC—multiple sclerosis	6.33e-06	0.000202	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	6.2e-06	0.000198	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	6.07e-06	0.000194	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ALB—multiple sclerosis	5.78e-06	0.000185	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.7e-06	0.000182	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	5.63e-06	0.00018	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—APOE—multiple sclerosis	5.24e-06	0.000168	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL2—multiple sclerosis	4.69e-06	0.00015	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	4.66e-06	0.000149	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—POMC—multiple sclerosis	4.5e-06	0.000144	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	4.44e-06	0.000142	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ALB—multiple sclerosis	4.11e-06	0.000131	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	3.94e-06	0.000126	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MYC—multiple sclerosis	3.66e-06	0.000117	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	3.66e-06	0.000117	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	3.59e-06	0.000115	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—APOE—multiple sclerosis	3.43e-06	0.00011	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.95e-06	9.41e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL6—multiple sclerosis	2.75e-06	8.8e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.69e-06	8.58e-05	CbGpPWpGaD
